Skip Navigation
School of Public Health homepageSearchSite Index
About the JHU Animal Care and Use Program

***THE ACUC OFFICE IS CLOSED UNTIL FURTHER NOTICE, but our staff are working from home.  Our review process is continuing as usual. 

Please submit all paperwork by e-mail only to .  Please do not fax, we will not be in to receive documents.***

Johns Hopkins Animal Care and Use Program

      2023 Protocol Schedule
Protocols Due
Meeting Dates
   January 3
   January 19
   February 1
   February 16
   March 1
   March 16
   April 3
   April 20
   May 1
   May 18
   June 1
   June 15
   July 3
   July 20
   August 17
   September 1
   September 21
   October 2
   October 19
   November 1
   November 16
   December 1
   December 21

Quick Links

Animal Care and Use Online Training
Animal Exposure Surveillance Questionnaire
Johns Hopkins "Blue book"
Drug formulary - all species

****Training Update****

In person classes for RODENT HANDLING and SMALL ANIMAL SURGERY are back!

Please check with the ACUC office at for details regarding date/time/place and how to sign up.






Animal Care and Use Online Training can be found under "Quick Links" or through "Important Links".  Pop-up Blocker must be turned OFF and you must have Adobe Flash Player version 8 or higher.    

*****BUPIVACAINE USERS-  Please Read*****

We have been informed that bupivacaine is currently on backorder for an extended period of time due to manufacturer delays.  If you are currently approved to use bupivacaine as a local anesthetic it is acceptable to substitute either lidocaine or ropivacaine without the need to submit an amendment.  The recommended dosages are as follows:

Lidocaine (2%)-  Dilute to 0.5%, do not exceed 7 mg/kg total dose

Ropivacaine (0.2%)-  No need to dilute, do not exceed 8 mg/kg total dose

If it is necessary to switch to either of these options please send an email to including the protocol number and which drug will be added to your protocol.

**ATTENTION Buprenorphine Users- UPDATED**

We have updated the policy (found under Policies and Guidelines) for use of extended release formulations of buprenorphine. These formulations are designed to eliminate the need for multiple dosing. If you are currently approved to use buprenorphine as an analgesic agent and would like to use one of these formulations we are allowing a substitution without the requirement of an amendment. An email must be sent to giving the protocol number and stating that extended release buprenorphine is being added to the protocol.  If you are not currently approved to use buprenorphine and would like to add this as an option then an amendment will need to be submitted.  The new policy provides a description of the drugs and dosing.  For ordering, please go to Important Links and click on Instructions for purchasing Buprenorphine SR and SRLab from ZooPharm. 



Print this page